Nov 14 (Reuters)-
Enbio Holdings, Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2024 Sep 30, 2023 Mar 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 5.96 5.48 10.91
(+8.7 pct) (-2.7 pct) (+14.0 pct)
Operating 772 mln 409 mln 818 mln
(+88.7 pct) (-70.3 pct) (+0.4 pct)
Recurring 639 mln 548 mln 674 mln
(+16.5 pct) (-64.1 pct) (-36.8 pct)
Net 415 mln 321 mln 450 mln
(+29.4 pct) (-67.0 pct) (-36.5 pct)
EPS 51.24 yen 41.11 yen 55.50 yen
Ann Div 8.00 yen 8.00 yen
-Q2 div NIL NIL
-Q4 div 8.00 yen 8.00 yen
NOTE - Enbio Holdings, Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6092.T